# Lilly del Caribe, Inc. – FDA Inspection, Jul 31, 2009

Source: https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/0fa8b6f9-1bcb-444c-8eed-141674da7034
Source feed: FDA_Inspections

> FDA inspection 600975 of Lilly del Caribe, Inc., July 31, 2009. Classification: Official Action Indicated (OAI). 1 citation under 21 CFR part 211. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 600975
- Company Name: Lilly del Caribe, Inc.
- Inspection Date: 2009-07-31
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1321482 - 2026-05-12
- [FDA Inspection 1198613 - 2023-02-17](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/c2c92c4c-c540-4128-90a5-30550b167b83)
- FDA Inspection 1069980 - 2018-09-27
- FDA Inspection 974723 - 2016-06-01
- FDA Inspection 868382 - 2014-02-21

Company: https://www.keypedia.com/companies/lilly-del-caribe-inc/7961ecde-19e4-4ccc-9701-c1979bc57aaa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c